These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. White JB; Fleming R; Masterson L; Ruddle BT; Zhong H; Fazenbaker C; Strout P; Rosenthal K; Reed M; Muniz-Medina V; Howard P; Dixit R; Wu H; Hinrichs MJ; Gao C; Dimasi N MAbs; 2019 Apr; 11(3):500-515. PubMed ID: 30835621 [TBL] [Abstract][Full Text] [Related]
6. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation. Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254 [TBL] [Abstract][Full Text] [Related]
7. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency. Beerli RR; Hell T; Merkel AS; Grawunder U PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162 [TBL] [Abstract][Full Text] [Related]
8. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry. Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282 [TBL] [Abstract][Full Text] [Related]
9. Current ADC Linker Chemistry. Jain N; Smith SW; Ghone S; Tomczuk B Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187 [TBL] [Abstract][Full Text] [Related]
10. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Phosphopantetheinyl Transferases. Grünewald J; Klock HE; Cellitti SE; Bursulaya B; McMullan D; Jones DH; Chiu HP; Wang X; Patterson P; Zhou H; Vance J; Nigoghossian E; Tong H; Daniel D; Mallet W; Ou W; Uno T; Brock A; Lesley SA; Geierstanger BH Bioconjug Chem; 2015 Dec; 26(12):2554-62. PubMed ID: 26588668 [TBL] [Abstract][Full Text] [Related]
11. Conjugation Site Analysis of Lysine-Conjugated ADCs. Sang H; Wan N; Lu G; Tian Y; Wang G; Ye H Methods Mol Biol; 2020; 2078():235-250. PubMed ID: 31643061 [TBL] [Abstract][Full Text] [Related]
12. A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab. Sijbrandi NJ; Merkul E; Muns JA; Waalboer DC; Adamzek K; Bolijn M; Montserrat V; Somsen GW; Haselberg R; Steverink PJ; Houthoff HJ; van Dongen GA Cancer Res; 2017 Jan; 77(2):257-267. PubMed ID: 27872093 [TBL] [Abstract][Full Text] [Related]
13. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. Li X; Patterson JT; Sarkar M; Pedzisa L; Kodadek T; Roush WR; Rader C Bioconjug Chem; 2015 Nov; 26(11):2243-8. PubMed ID: 26161903 [TBL] [Abstract][Full Text] [Related]
14. Site-Specific Antibody-Drug Conjugates in Triple Variable Domain Fab Format. Hwang D; Rader C Biomolecules; 2020 May; 10(5):. PubMed ID: 32422893 [TBL] [Abstract][Full Text] [Related]
15. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969 [TBL] [Abstract][Full Text] [Related]
16. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis. Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567 [TBL] [Abstract][Full Text] [Related]